Market Report · July 31, 2026
Report Feature
Precision Pathology Service Market Trends and Forecast
The future of the global precision pathology service market looks promising with opportunities in the hospital & diagnostic centers, laboratories & research institutes markets. The global precision pathology service market is expected to grow with a CAGR of 7.9% from 2025 to 2031. The major drivers for this market are increasing demand for personalized medicine are fueling the growth, the rising prevalence of chronic diseases, and advancements in medical technologies. Lucintel forecasts that, within the type category, histopathology is expected to witness the highest growth over the forecast period due to given the high volume of tissue biopsies performed for cancer and other diseases. Within the application category, hospital & diagnostic centers is expected to witness the higher growth due to increasing demand for personalized treatment plans. In terms of region, North America will remain the largest region over the forecast period due to hospitals, diagnostic centers, and research institutes in the u.s. frequently utilize. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Precision Pathology Service Market by Segment
• Next-Generation Sequencing in Molecular Diagnostics: NGS technology is revolutionizing molecular diagnostics, offering detailed genetic insights into diseases, particularly cancer. NGS enables pathologists to analyze the genetic makeup of tumors, leading to more accurate diagnoses and personalized treatment plans. This technology is crucial for identifying mutations that may be targeted by specific therapies, enhancing the effectiveness of treatments. As the cost of NGS continues to decrease, its widespread adoption in precision pathology services is expected to grow, making it an indispensable tool in clinical and research applications.
• Digital Pathology and Telepathology: Digital pathology, which involves converting traditional slides into high-resolution digital images, is becoming an essential part of precision pathology services. This technology enables pathologists to collaborate remotely, streamlining workflows and improving access to expert opinions. Telepathology, a subset of digital pathology, is also gaining traction, particularly in underserved or remote areas. This trend is enabling faster diagnosis and improving the accuracy of pathology results, particularly for complex or rare diseases, by facilitating consultations with specialists around the globe.
• Personalized Cancer Care: Personalized cancer care is a major driver of growth in the precision pathology service market. Pathology services are increasingly focusing on tumor profiling and molecular diagnostics to tailor treatment plans based on the genetic and molecular characteristics of individual patients’ tumors. This trend has led to the development of precision oncology, which aims to deliver targeted therapies that improve treatment efficacy and minimize side effects. With growing cancer rates globally, the demand for personalized cancer diagnostics and treatments is likely to expand rapidly.
• Focus on Early Disease Detection: There is a growing focus on the early detection of diseases, especially cancer, through precision pathology services. Early diagnosis allows for more effective treatment and better patient outcomes. Advances in molecular biomarkers and liquid biopsy are making it possible to detect diseases before symptoms appear, which can significantly improve prognosis. As healthcare providers and researchers prioritize preventive care and early detection, the precision pathology service market is expected to see significant growth in applications related to early disease screening. Emerging trends such as AI integration, digital pathology, genomic testing, real-time data analytics, and the global expansion of personalized medicine are reshaping the precision pathology service market. These trends are driving the development of more efficient, accurate, and personalized diagnostic services, improving patient outcomes across the world." src="Emerging Trends in the Precision Pathology Service Market" style="height: auto;width: auto;" title="The precision pathology service market is being shaped by emerging trends that focus on enhancing diagnostic accuracy, optimizing treatment regimens, and reducing healthcare costs. Technological innovations, such as AI and next-generation sequencing (NGS), are key to these trends, which are transforming pathology services from a traditional field into a more data-driven, personalized healthcare service. Below are the top emerging trends reshaping this market.
• Integration of Artificial Intelligence (AI) in Pathology: AI is being integrated into precision pathology services to improve diagnostic accuracy, speed, and efficiency. AI algorithms can analyze large datasets from tissue samples, identifying patterns that might be missed by human pathologists. The growing adoption of AI in digital pathology allows for better detection of cancerous cells, more accurate tissue analysis, and improved patient outcomes. This trend is particularly transformative in oncology, where AI-driven pathology can enable personalized cancer treatments based on genetic and molecular profiles.
• Next-Generation Sequencing in Molecular Diagnostics: NGS technology is revolutionizing molecular diagnostics, offering detailed genetic insights into diseases, particularly cancer. NGS enables pathologists to analyze the genetic makeup of tumors, leading to more accurate diagnoses and personalized treatment plans. This technology is crucial for identifying mutations that may be targeted by specific therapies, enhancing the effectiveness of treatments. As the cost of NGS continues to decrease, its widespread adoption in precision pathology services is expected to grow, making it an indispensable tool in clinical and research applications.
• Digital Pathology and Telepathology: Digital pathology, which involves converting traditional slides into high-resolution digital images, is becoming an essential part of precision pathology services. This technology enables pathologists to collaborate remotely, streamlining workflows and improving access to expert opinions. Telepathology, a subset of digital pathology, is also gaining traction, particularly in underserved or remote areas. This trend is enabling faster diagnosis and improving the accuracy of pathology results, particularly for complex or rare diseases, by facilitating consultations with specialists around the globe.
• Personalized Cancer Care: Personalized cancer care is a major driver of growth in the precision pathology service market. Pathology services are increasingly focusing on tumor profiling and molecular diagnostics to tailor treatment plans based on the genetic and molecular characteristics of individual patients’ tumors. This trend has led to the development of precision oncology, which aims to deliver targeted therapies that improve treatment efficacy and minimize side effects. With growing cancer rates globally, the demand for personalized cancer diagnostics and treatments is likely to expand rapidly.
• Focus on Early Disease Detection: There is a growing focus on the early detection of diseases, especially cancer, through precision pathology services. Early diagnosis allows for more effective treatment and better patient outcomes. Advances in molecular biomarkers and liquid biopsy are making it possible to detect diseases before symptoms appear, which can significantly improve prognosis. As healthcare providers and researchers prioritize preventive care and early detection, the precision pathology service market is expected to see significant growth in applications related to early disease screening. Emerging trends such as AI integration, digital pathology, genomic testing, real-time data analytics, and the global expansion of personalized medicine are reshaping the precision pathology service market. These trends are driving the development of more efficient, accurate, and personalized diagnostic services, improving patient outcomes across the world." />
Emerging Trends in the Precision Pathology Service Market
Recent Development in the Precision Pathology Service Market
The precision pathology service market has experienced a wave of innovations in recent years, with notable developments in technology, service offerings, and market growth across key regions. Below are five key developments that are driving change in this market and reshaping its future.• AI-Powered Pathology Solutions: AI-powered pathology services have gained significant traction in the market. Companies are incorporating AI algorithms to analyze pathological images and data more efficiently. AI tools help identify key biomarkers and tissue structures, which can improve the accuracy of diagnoses and the speed at which they are delivered. This technology is particularly important in fields like oncology, where early and accurate detection of tumors is critical. By reducing human error, AI-powered solutions are transforming pathology from a traditional field into a high-tech, data-driven service.
• Advancements in Next-Generation Sequencing (NGS): NGS technology has seen significant advancements, especially in the areas of cost reduction and speed. The improved accessibility of NGS is making it a standard tool in precision pathology services, enabling more detailed and comprehensive genetic analysis of diseases. This has paved the way for better understanding of complex diseases like cancer, allowing for more personalized treatment plans. As NGS continues to evolve, it is expected to become a routine diagnostic tool in clinical settings, with its application expanding into various fields of precision medicine.
• Digital and Telepathology Expansion: Digital pathology and telepathology are rapidly expanding, enabling pathologists to digitize traditional glass slides into high-resolution images that can be shared globally. This shift is improving collaboration among pathologists, speeding up diagnoses, and increasing access to specialized expertise. In remote or underserved areas, telepathology is playing a crucial role in providing expert pathology services. These advancements in digital technology have not only enhanced the accuracy and efficiency of pathology services but also democratized access to high-quality diagnostic care.
• Rise of Liquid Biopsy in Early Disease Detection: Liquid biopsy, which involves analyzing blood or other bodily fluids for genetic material, has emerged as a promising tool for early disease detection, particularly in cancer. It offers a non-invasive, quicker alternative to traditional biopsies. Precision pathology services are increasingly incorporating liquid biopsy techniques to detect cancer at early stages when treatment is more effective. This non-invasive approach is expected to revolutionize cancer diagnostics and increase the adoption of precision pathology services for early detection.
• Government Investments in Precision Medicine: Governments around the world, particularly in the U.S., China, and Germany, are making substantial investments in precision medicine and diagnostics. These investments are helping to drive innovation in precision pathology services, funding research into new diagnostic techniques, and promoting the development of personalized treatments. Government-backed initiatives are accelerating the adoption of advanced diagnostic technologies, including genomic testing, AI, and digital pathology, ensuring that precision pathology services continue to improve and expand their reach globally. Recent developments in the precision pathology service market, including the integration of AI, digital pathology, molecular profiling, and telemedicine, are transforming the landscape of diagnostics. These innovations are improving the accuracy, efficiency, and accessibility of pathology services, particularly in cancer care, and are driving the shift toward more personalized treatment approaches.
Strategic Growth Opportunities in the Precision Pathology Service Market
The precision pathology service market presents significant growth opportunities across a variety of applications, driven by innovations in molecular diagnostics, AI, and digital pathology. As the demand for personalized healthcare rises, these applications are expected to play a critical role in shaping the future of the market.• Oncology: Oncology is one of the largest growth opportunities for precision pathology services. The increasing prevalence of cancer globally and the need for personalized treatment regimens have led to a growing demand for tumor profiling, genetic testing, and molecular diagnostics. Precision pathology services that provide insights into tumor characteristics, mutations, and response to therapies are essential for personalized cancer care, representing a critical opportunity for growth.
• Genetics and Rare Diseases: Precision pathology is becoming increasingly important in the diagnosis and management of rare genetic disorders. The rise of genetic testing, alongside the availability of targeted therapies, creates an opportunity for precision pathology services to play a key role in diagnosing and treating rare diseases. This market is expected to grow significantly as genetic testing becomes more accessible and effective.
• Cardiology: Precision pathology services are expanding into cardiology, where genetic testing and molecular profiling are used to understand cardiovascular diseases better. With the rise in heart disease worldwide, precision pathology can help identify genetic markers that predict heart disease risk and improve treatment strategies, driving growth in the cardiology market.
• Neurology: Precision pathology services are becoming increasingly important in neurology, particularly for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. With advancements in biomarkers and molecular diagnostics, precision pathology is helping to identify early signs of these conditions and personalize treatment plans. As these diseases become more prevalent due to aging populations, the demand for specialized pathology services is expected to grow.
• Veterinary Medicine: In veterinary medicine, precision pathology services are being applied to diagnose and treat diseases in animals, including cancer and genetic disorders. As pet ownership increases and demand for specialized veterinary care grows, precision pathology services are becoming a crucial tool for veterinarians to deliver personalized treatment for pets, creating a new and expanding market opportunity. The precision pathology service market presents numerous strategic growth opportunities across oncology, genetic testing, AI integration, telepathology, and infectious disease diagnostics. These opportunities are driven by advancements in technology and the growing demand for personalized medicine. Companies that capitalize on these trends will be well-positioned to grow their market share and enhance patient care outcomes.
Precision Pathology Service Market Driver and Challenges
The precision pathology service market is shaped by a variety of technological, economic, and regulatory factors. The major drivers include advances in molecular diagnostics, increased demand for personalized healthcare, and innovations in AI and digital pathology. However, challenges such as high costs, regulatory complexities, and the need for specialized workforce training remain obstacles. Below are key drivers and challenges influencing the market. The factors responsible for driving the Precision Pathology Service market include: 1. Advances in Molecular Diagnostics: The rapid evolution of molecular diagnostics, including genetic testing and next-generation sequencing, is a key driver. These technologies enable more precise diagnoses and personalized treatments, particularly in oncology. Their integration into precision pathology services is enhancing diagnostic accuracy and improving patient outcomes. 2. Rising Demand for Personalized Medicine: The growing trend toward personalized healthcare is driving demand for precision pathology services. With a focus on tailoring treatments to individual genetic profiles, precision pathology is crucial for enabling personalized cancer therapies, targeted treatments for genetic disorders, and other individualized care strategies. 3. AI and Digital Pathology Innovations: The integration of AI in pathology workflows is enhancing the accuracy, efficiency, and speed of diagnoses. AI-driven tools can analyze large volumes of data, identifying subtle patterns and abnormalities that may be missed by human pathologists, improving patient outcomes and enabling faster, more accurate diagnoses. 4. Increased Healthcare Investments: Government and private investments in healthcare infrastructure, particularly in emerging markets, are supporting the growth of precision pathology services. These investments enable the adoption of advanced diagnostic tools and technologies, improving access to high-quality diagnostic services and fostering growth in the market. 5. Population Aging and Chronic Disease Burden: As populations age and the prevalence of chronic diseases, including cancer and heart disease, increases, the demand for precision pathology services will continue to rise. Accurate early detection and personalized treatment plans for these diseases are critical, driving growth in the precision pathology sector. Challenges in the Precision Pathology Service market are: 1. High Costs of Advanced Diagnostics: The cost of implementing advanced diagnostic technologies, such as next-generation sequencing and AI-powered tools, remains a significant barrier. Healthcare facilities, particularly in developing markets, may struggle to afford the infrastructure and training needed to integrate these technologies. 2. Regulatory Hurdles: Regulatory frameworks for precision pathology services can be complex and vary across regions. Navigating regulatory approval processes for new technologies and ensuring compliance with international standards can delay the availability of new services and increase costs. 3. Shortage of Trained Pathologists: The growing demand for precision pathology services is creating a shortage of trained professionals. Pathologists require specialized training in molecular diagnostics, AI technologies, and digital pathology to meet the needs of modern healthcare systems, and there is a gap in workforce development. The precision pathology service market is poised for significant growth, driven by advances in molecular diagnostics, AI, and digital technologies. However, the sector faces challenges such as high costs, regulatory complexities, and workforce shortages. As governments and private entities invest in healthcare infrastructure and innovation, the precision pathology service market is expected to continue evolving, with opportunities across oncology, genetics, and personalized medicine reshaping the healthcare landscape.List of Precision Pathology Service Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies precision pathology service companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the precision pathology service companies profiled in this report include-• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific
• Abbott Laboratories
• BD
• Siemens Healthineers
• Philips
• Phc Holdings
• Agilent
• Sakura Finetek
Precision Pathology Service Market by Segment
The study includes a forecast for the global precision pathology service market by type, application, and region.Precision Pathology Service Market by Type [Value from 2019 to 2031]:
• Histopathology
• Cytopathology
• Immunohistochemistry
• Molecular Pathology
Precision Pathology Service Market by Application [Value from 2019 to 2031]:
• Hospital & Diagnostic Centers
• Laboratories & Research Institutes
Precision Pathology Service Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Precision Pathology Service Market
The global precision pathology service market has been undergoing rapid transformation, driven by technological advancements, rising demand for personalized medicine, and a greater focus on early and accurate disease diagnosis. Precision pathology services offer highly accurate and tailored diagnostic insights, crucial for personalized treatment planning, especially in oncology, genetics, and other critical health areas. Countries like the United States, China, Germany, India, and Japan are leading this transformation, with significant investments in healthcare infrastructure, research, and AI-driven innovations. Below are key developments in the precision pathology service market across these nations, along with emerging trends and growth opportunities.• United States: The United States continues to lead the precision pathology service market, driven by advancements in genomics, AI integration, and a growing demand for personalized treatment. Major players are increasingly adopting artificial intelligence (AI) to enhance diagnostic accuracy and reduce turnaround times for pathology reports. Precision oncology is a key area of growth, with services focusing on tumor profiling and genetic testing to guide personalized cancer treatments. The market is further supported by increasing investments in molecular diagnostics and advanced imaging technologies, aimed at improving the precision and efficiency of pathology services across various healthcare settings.
• China: China’s precision pathology service market has seen rapid growth in recent years, fueled by government initiatives to improve healthcare infrastructure and expand access to advanced diagnostic tools. With rising cases of chronic diseases such as cancer, there is a growing demand for precision pathology services, particularly in oncology. Chinese companies are increasingly adopting AI-powered pathology tools to enhance diagnostic capabilities, and the government is encouraging investments in precision medicine. Additionally, collaborations between local hospitals and global tech companies have contributed to the development of more sophisticated pathology services, including genetic testing and molecular profiling.
• Germany: Germany is a major player in the European precision pathology service market, with a focus on integrating AI, next-generation sequencing (NGS), and digital pathology into clinical settings. The demand for precision medicine, particularly in cancer care, has been on the rise, with precision pathology services being used to better tailor treatments based on individual patient profiles. German healthcare systems are increasingly investing in digital platforms and AI solutions that enable pathologists to conduct more accurate diagnoses and improve patient outcomes. This is leading to a greater shift towards personalized, data-driven healthcare solutions across the country.
• India: India’s precision pathology service market is growing rapidly, driven by the rising prevalence of lifestyle diseases, cancer, and a burgeoning demand for high-quality diagnostics. With increasing access to affordable genetic testing and molecular profiling, there is a shift towards precision diagnostics in India, particularly in major urban centers. Additionally, India is witnessing a rise in collaborations between local healthcare providers and international players, which is accelerating the adoption of advanced pathology technologies. The government’s focus on improving healthcare access and quality through the National Health Mission is also boosting the demand for precision pathology services in the country.
• Japan: Japan is investing heavily in precision pathology services, with a strong focus on integrating cutting-edge technologies like AI, digital pathology, and molecular diagnostics. The country has a well-established healthcare system, and the aging population is driving the demand for accurate and early disease detection, particularly in cancer. Japanese healthcare institutions are increasingly turning to advanced diagnostic tools, including precision pathology services, to improve clinical decision-making. Additionally, Japan’s robust research infrastructure supports the integration of AI and next-generation sequencing (NGS) into pathology, enhancing the country’s capacity to deliver personalized healthcare solutions.
Features of the Global Precision Pathology Service Market
Market Size Estimates: Precision pathology service market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions. Segmentation Analysis: Precision pathology service market size by type, application, and region in terms of value ($B). Regional Analysis: Precision pathology service market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the precision pathology service market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the precision pathology service market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for precision pathology service market? Answer: The global precision pathology service market is expected to grow with a CAGR of 7.9% from 2025 to 2031. Q2. What are the major drivers influencing the growth of the precision pathology service market? Answer: The major drivers for this market are increasing demand for personalized medicine are fueling the growth, the rising prevalence of chronic diseases, and advancements in medical technologies. Q3. What are the major segments for precision pathology service market? Answer: The future of the precision pathology service market looks promising with opportunities in the hospital & diagnostic centers, laboratories & research institutes markets. Q4. Who are the key precision pathology service market companies? Answer: Some of the key precision pathology service companies are as follows:• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific
• Abbott Laboratories
• BD
• Siemens Healthineers
• Philips
• Phc Holdings
• Agilent
• Sakura Finetek Q5. Which precision pathology service market segment will be the largest in future? Answer: Lucintel forecasts that histopathology is expected to witness the highest growth over the forecast period due to given the high volume of tissue biopsies performed for cancer and other diseases. Q6. In precision pathology service market, which region is expected to be the largest in next 5 years? Answer: North America will remain the largest region over the forecast period due to hospitals, diagnostic centers, and research institutes in the u.s. frequently utilize. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.
Table of Contents
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising, high-growth opportunities for the precision pathology service market by type (histopathology, cytopathology, immunohistochemistry, and molecular pathology), application (hospital & diagnostic centers and laboratories & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which region will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- • What are the business risks and competitive threats in this market?
- • What are the emerging trends in this market and the reasons behind them?
- • What are some of the changing demands of customers in the market?
- • What are the new developments in the market? Which companies are leading these developments?
- • Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- • What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- • What M&A activity has occurred in the last 5 years and what has its impact been on the industry? For any questions related to Precision Pathology Service Market, Precision Pathology Service Market Size, Precision Pathology Service Market Growth, Precision Pathology Service Market Analysis, Precision Pathology Service Market Report, Precision Pathology Service Market Share, Precision Pathology Service Market Trends, Precision Pathology Service Market Forecast, Precision Pathology Service Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
